Medica Group PLC
LSE:MGP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (6.8), the stock would be worth GBX211 (0% upside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.8 | GBX211 |
0%
|
| 3-Year Average | 6.8 | GBX211 |
+0%
|
| 5-Year Average | 6.8 | GBX211 |
+0%
|
| Industry Average | 0 | GBX0.28 |
-100%
|
| Country Average | 0 | GBX0.29 |
-100%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Medica Group PLC
LSE:MGP
|
258.3m GBP | 6.8 | 35.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
105.9B USD | 2.8 | 59.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 4.1 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
76.6B USD | 0 | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 5.6 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 5.8 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 7 | 21.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 6.4 | 24.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 3.4 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 18.8 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 4.5 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 664.3 |
Other Multiples
Medica Group PLC
Glance View
Medica Group Plc engages in the provision of teleradiology reporting services. The company is headquartered in Hastings, Sussex and currently employs 207 full-time employees. The company went IPO on 2017-03-21. The firm provides outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerized tomography), ultrasound and plain film (x-ray) images. The firm operates through three geographic segments: UK, Ireland, and the US. The UK segment includes two primary services to hospital radiology departments: NightHawk and Elective. The NightHawk provides reporting services. The Elective offers cross-sectional reporting on MRI and CT scans, and plain film reporting on X-radiation (x -ray) images. The Ireland segment provides tele-radiology, managed services and a contract with the National Screening Service to deliver Ophthalmology services. The US segment provides radiology reporting to Pharma customers directly and indirectly via contract research organizations (CRO's). The company also provides diabetic retinopathy screening services.
